Holen Sie sich die Stockscreener-App
0.307
5.83%
-0.019
Handel nachbörslich:
.30
-0.007
-2.28%
Schlusskurs vom Vortag:
$0.326
Offen:
$0.321
24-Stunden-Volumen:
1.01M
Relative Volume:
0.17
Marktkapitalisierung:
$9.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-0.267
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-24.37%
1M Leistung:
-37.47%
6M Leistung:
-57.98%
1J Leistung:
-85.65%
1-Tages-Spanne:
$0.2907
$0.3226
1-Wochen-Bereich:
$0.2907
$0.4326
52-Wochen-Spanne:
$0.2907
$2.39
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
0.307 | 9.66M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
What is the risk reward ratio of investing in Acurx Pharmaceuticals Inc. stockAccelerated wealth expansion - jammulinksnews.com
How does Acurx Pharmaceuticals Inc. compare to its industry peersBuild a winning investment strategy - jammulinksnews.com
Chart based exit strategy for Acurx Pharmaceuticals Inc.Intelligent Trade Forecast With AI Analytics - newser.com
What institutional investors are buying Acurx Pharmaceuticals Inc. stockOutstanding risk-reward balance - jammulinksnews.com
How strong is Acurx Pharmaceuticals Inc. company’s balance sheetFree Stock Chart Pattern Guide - jammulinksnews.com
What is the dividend policy of Acurx Pharmaceuticals Inc. stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com
Acurx Pharmaceuticals Inc. Stock Analysis and ForecastBuild a portfolio that stands the test of time - jammulinksnews.com
What makes Acurx Pharmaceuticals Inc. stock price move sharplyAchieve consistent profits with proven methods - jammulinksnews.com
Is Acurx Pharmaceuticals Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
How volatile is Acurx Pharmaceuticals Inc. stock compared to the marketAchieve breakthrough investment performance - jammulinksnews.com
Acurx Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - AInvest
What are the latest earnings results for Acurx Pharmaceuticals Inc.Explosive capital appreciation - jammulinksnews.com
Is it the right time to buy Acurx Pharmaceuticals Inc. stockDiscover market opportunities others miss - jammulinksnews.com
Does Acurx Pharmaceuticals Inc. stock perform well during market downturnsHigh-yield capital appreciation - jammulinksnews.com
What are analysts’ price targets for Acurx Pharmaceuticals Inc. in the next 12 monthsInvest smarter with data-backed insights - jammulinksnews.com
Acurx Pharmaceuticals To Carry Out 1-for-20 Reverse Stock Split On August 5th, 2025 - 富途牛牛
Heatmap analysis for Acurx Pharmaceuticals Inc. and competitorsPrice Action Summary and Entry Strategy Guide - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Exit and Entry Price Prediction - Newser
Company’s Banking Shares: Up -87.00% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com
Why is Acurx Pharmaceuticals Inc. stock attracting strong analyst attentionPre Market Review For Consistent Profits - jammulinksnews.com
Should I hold or sell Acurx Pharmaceuticals Inc. stock in 2025Top Growth Tracker With Low Risk - jammulinksnews.com
How Acurx Pharmaceuticals Inc. stock performs during market volatilityAI-Based Reversal Point Prediction Signal - newser.com
Multi asset correlation models including Acurx Pharmaceuticals Inc.Swing Gain Strategy with Entry Forecast - newser.com
How moving averages guide Acurx Pharmaceuticals Inc. tradingFree AI Forecast for Trending Stocks - newser.com
Technical signs of recovery in Acurx Pharmaceuticals Inc.Value Investing Summary and Earnings Outlook - Newser
Acurx Pharmaceuticals Approves Reverse Stock Split to Regain Nasdaq Compliance - AInvest
Acurx Pharmaceuticals Announces 1-For-20 Reverse Stock Split, Trading Post-Split On August 5, 2025 - 富途牛牛
Acurx Pharmaceuticals Plans Major 1:20 Reverse SplitKey Details for Nasdaq Compliance - Stock Titan
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Free Daily Top Performing Stock Insights - Newser
What risks could impact Acurx Pharmaceuticals Inc. stock performanceStock Portfolio Risk and Return Analysis - Newser
Sector Rotation Brings Acurx Pharmaceuticals Inc. Into FocusTriple Digit Return Stock Predictions Released - metal.it
Can Acurx Pharmaceuticals Inc. Regain Lost Ground This QuarterRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Published on: 2025-07-29 10:12:38 - metal.it
Acurx Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftWatchlist for Smart Swing Trading Updated - metal.it
What high frequency data says about Acurx Pharmaceuticals Inc.Intraday Price Forecast Using Volume Models - Newser
What are Acurx Pharmaceuticals Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - jammulinksnews.com
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):